A three-day accelerated management programme to give you the high-performance management skills of an MBA, designed specifically for pharmaceutical/biotechnology professionals and also applicable to medical device/animal health industries
13-15 May 2020
& 11-13 Nov 2020
GBP 1,799 1,499 *
EUR 2,519 2,099 *
USD 2,806 2,338 *
* When you book before 3 Apr
Working in the highly competitive pharmaceutical industry, with ever-increasing change and pressure, is probably one of the most challenging managerial roles of any industry today. This event has been especially designed to help you transcend these challenges by training you to become equipped to see the bigger picture in all aspects of your role. It will help you build your management skills for the future and prepare you to fulfil your ambitions.
The Pharma Mini MBA accelerated management programme is a distillation of the most valuable parts of an MBA, as applied to the pharmaceutical industry. It will provide you with practical management tools to apply in the workplace, as well as giving a real taste of an MBA course with the pharmaceutical case studies from business schools.
Pharmaceutical industry context – business school pharmaceutical case studies on each module
This intensive three-day course will help you to translate your learning into new behaviours and improvements in your capability and performance and will work through live issues impacting on the industry and on you directly. The individual and group exercises will focus on pharmaceutical/biopharma/generic MBA case studies, and also on your own challenges and examples. The business school case studies will help give the ‘feel’ of a full MBA and help you understand more about the strategies used in today’s pharmaceutical and associated industries.
The Pharma Mini MBA is also an invaluable guide to all that is best and most practical on an MBA course – with specific focus on the pharmaceutical sector. It is also of value either to gain the most useful aspects of an MBA or as an MBA taster, providing a foundation of the essential MBA elements to apply directly to your role. The pharmaceutical industry requires employees to focus on successful leadership and business management skills, which this programme is designed to give you.
The skills you will improve include:
Residential option available to include 2 nights bed & breakfast – select at checkout.
MBA learning style of the programme
The Pharma Mini MBA learning style is ‘hands-on’ rather than academic. The programme is very practical, without being too theoretical, with industry-relevant case studies drawn from business school cases. The course covers the key areas of an MBA and applies these MBA tools and concepts to the pharmaceutical industry, providing you with a firm foundation of the essential MBA thinking and terminology. Three modules will be covered in just three days of interactive workshops to enhance the value of the course and, to minimise your time away from the office, there is also optional pre- and post-course work set by the programme director.
A ‘must-attend’ for professionals in the pharmaceutical/biopharma/medical device/animal health industries wishing to develop their business management skills for more senior levels and beyond mere technical ability. It will also help anyone thinking of studying for an MBA who would like an idea of what is involved. It is particularly beneficial to attend with a colleague to maximise the practical learning.
Introduction, welcome and key objectives of the course
Commercial management and leadership in the pharma industry
- What are the core competencies of effective leaders in pharma?
- Leadership vs management
- Leadership style and approaches in the pharma industry
Leading and implementing pharma strategy and change
Leading successful change
- Diagnosis around change
- How to create the conditions for successful change
- Why people resist change and how to manage this
- Change management including leading a structural reorganisation
- Creating a team, department and organisation relevant to today’s pharma business needs
- Team formation and development
Implementing strategy and change, essentials of planning and managing projects
- Project management tools and techniques to use in implementing pharma projects
- Applying key project management techniques to pharma projects
- Understanding of cultural awareness to work more effectively with pharma colleagues
Hot topics in market access strategy
Practical application/review
Laura Brown (13-15 May 2020, 11-13 Nov 2020)
Dr Laura Brown is a management consultant and psychologist in the highly regulated pharmaceutical
and legal industries, where she has worked with numerous leading organisations including Cranfield
School of Management and most of the top 20 pharma/biotechnology companies. She is also the Course Director of a pharmaceutical MSc at
the University of Cardiff. Besides a PhD and an MBA, Laura also has a degree in psychology and is co-author of several management books
including Developing the Individual.
Leela Barham (13-15 May 2020)
BSc (Economics), MSc (Health Economics)
Leela Barham is an independent health economist and policy expert working on a freelance basis. This follows 7 years at a specialist economic consulting firm working in a small dedicated health and pharmaceutical team.
She has more than 10 years experience in the pharmaceutical industry – both at home and abroad – and has worked for all stakeholders in the health care system ranging from patient organisations, the National Health Service, health insurers, and the pharmaceutical industry.
She has particular expertise in public and patient involvement, Patient Access Schemes/risk sharing schemes, the Cancer Drugs Fund, policy on Health Technology Assessment (HTA), and the Pharmaceutical Price Regulation Scheme (PPRS). She regularly writes on hot topics affecting the industry for Pharmaceutical Executive, Pharmaphorum and EyeforPharma and has also written for PharmaTimes, and Pharma Pricing and Reimbursement. She has also had her research published in peer review journals including The Patient and Pharmacoeconomics.
Nick Meadows (13-15 May 2020)
Nick Meadows has over 12 years of experience working in the life sciences industry as a management consultant, technology transfer analyst and medical research scientist. In 2016 he joined Strategy& (part of the PwC network) where he is supporting clients within the pharmaceutical industry address strategic and operational challenges in development and commercial functions. As a consultant he has managed engagements across research and development and commercial functions of the life sciences and pharmaceutical industry. In the past 5 years his work has spanned major transformational projects in clinical operations, research and development, to and commercial strategy through direct engagement with program teams and commercial leads. In his former role at Kinapse (2011 – 2016) he led the market access service line where he supported clients optimise pricing and reimbursement outcomes for launching and development products.In addition he has collaborated with regulators, policy makers and healthcare practitioners to provide recommendations to accelerate the development of personalised medicines. He has also developed a deep understanding of the biosimilars landscape.He holds an MBA from Saïd Business School, University of Oxford, and a PhD and BSc (Hons) in Molecular Biology from University of Queensland, Brisbane, Australia.
Laura Brown (13-15 May 2020, 11-13 Nov 2020)
Dr Laura Brown MBA, BSc,PhD, is a Pharmaceutical QA and Training Consultant, Course Director for the MSc in Clinical Research, School of Pharmacy at the University of Cardiff. She has more than 20 years’ experience of quality assurance in the pharmaceutical industry and has worked for several companies, including GSKs Hoechst Marion Roussel, Farmitalia and Phoenix International. She has a particular expertise in quality assurance including risked based approaches to quality systems, data Integrity and project management in the pharmaceutical industry. She regularly writes on pharmaceutical regulatory issues including “The Planning of International Drug Development”, in the Clinical Research Manual, Euromed and the “Impact of Brexit”, RQA Journal 2017.
| 13-15 May 2020 | ||||
| 13-15 May 2020 | Rembrandt Hotel, London | GBP 1,799.00 EUR 2,519.00 USD 2,806.00 + VAT @ 20.00% |
GBP 1,499.00 EUR 2,099.00 USD 2,338.00 Until 3 Apr* |
Enrol now |
| 11-13 Nov 2020 | ||||
| 11-13 Nov 2020 | Rembrandt Hotel, London | GBP 1,799.00 EUR 2,519.00 USD 2,806.00 + VAT @ 20.00% |
Enrol now | |
* Note the early booking discount cannot be combined with any other offers or promotional code
“Course very useful to get an overview of what a MBA could be. Laura makes the course very interactive and really interesting with many real life examples. Her knowledge of the global pharma industry is quite impressive.”
Camille Rivail, Senior Manager Business Development, Avadel Pharmaceuticals SA
“Thank you for a great learning experience!”
Jasper Deuring, Medical Affairs , Pfizer
“Laura Brown is a very interesting speaker”
Mehdi Sellami, Scientific Director, Laboratoires Galpharma
“Good coverage of wide topic area, extremely useful for someone from a single function to get wider overview”
Mark Andrews, Technical Director / QP, Deputy Managing Director, Torbay and South Devon NHS Foundation Trust
“The course gave a real insight into the MBA. There were so many tools I could take back with me and apply to my working life not only for myself , but for my colleagues. The course was a great mix of theory, case studies, external talks and media. Laura was extremely knowledgeable with great credibility within the industry. The course has made me consider a full MBA and also exploring what other courses have Laura as the trainer.”
Emma Lennon, Group Manager, GW Pharmaceuticals
“I think this was a very useful, practical and interesting course. I was able to adopt a strategic thinking that I will be able to implement in my work. ”
Aintzane Garcia, Medical Department, Faes Farma SA
“For a 3 day course, we covered a good spread of techniques and information. Having the talks sparked thoughts and also provided a change of pace. The speakers were excellent and Laura's energy & experience was very much appreciated.”
Lorraine Borland, Director, Strategic Projects, Sartorius-Stedim BioOutsource
“Great energy. Best training I had in a long time. ”
Florent Noel, Sr Manager QA, Covis Pharma
“Laura [was] very engaging, varied content, good level, Not one boring moment! Deming [offered a] good practical experience in pharma. Great to have had a chance to practically use the tools Laura recommended. ”
Emma Dupree, Associate Director, Compliance, AbbVie
“Overall good, too little time!”
Janni Hermansen, Senior PV Advisor, LEO Pharma
“Very interesting”
Emine Akin, Marketing & Sales Junior Assistant, Chiesi Group
“Really good overview and opportunity to ask many questions. Great course.”
Luisa Teixeira, Account Manager, Owen Mumford Ltd
“Laura is a very dynamic person that knows very well how to deliver a message. The topics are very interesting from the pharma/management point of view and articulated
- Would be interesting to have topic about pharma at geographical level”
Janneth Ospina Paladines, Senior Regulatory Affairs Associate, Gilead Sciences International
“Course was very condensed either reduce the content or extend the course days”
Aziz-ul-Islam Chaudhry, Head of Regulatory Affairs, Martindale Pharma
“I found it really practical, lively with possibility to exchange experiences”
Mireille Pierrevelcin, Export Area Manager, Cesra Arzneimittel GmbH & Co
“The course is very good. Gives you in three days an overall view on core subjects that management people need to know to improve. Case studies were excellent and realistic. Speakers were great ”
Diana Binkert, Acino International AG
“It was a very nice overview on MBA topics overview on MBA topics with a great speaker and interesting discussions”
Ricarda Tiemeyer, Drug Safety Scientist & Deputy LSR, Roche Pharma (Switzerland) AG
“Excellent. Thoroughly enjoyed it and left feeling like I had learnt something, which, at the end of the day, is the primary goal. I appreciated the method of teaching and enjoyed meeting other people on the course.”
Zain Masters, Business Development & Licensing Director, Masters Speciality Pharma
“It exceeded my expectations. Really enjoyed practical sessions and focused environment.”
Andriy Kirmach, Associate Director, International Compliance & Ethics, Allergan
“Overall excellent course, very well organized. Suitable content, stimulating presentations and excellent speakers.”
Suna Horner, Associate Medical Manager, HRA Pharma UK & Ireland Ltd
“Provided exactly what I required”
Peter Gaines, Chief Medical Officer, Veryan Medical Limited
“Good mix of people and perspectives; venue was easy to get to. Guest speakers were a good idea.”
Julie-Anne Webb, Inside Sales Associate - EU, Core Informatics
“Excellent trainer, lots of info in a short time but actually by the end I thought it was a suitable duration and speed. Would have been nicer to have a little more on the PM part at the end simply because that fits better with my role.”
Julia Caldwell, Clinical Trial Manager, Allergan
“It was rushed in places with things being skipped over - its good to try and include a lot but not if its skipped...doesn't help ”
GEOF WOLFENDEN, IP & Contracts Manager, AstraZeneca
“It was very informative and engaging with real potential to help with daily practicalities. The full content and delivery is hitting the mark in my opinion.”
Irem Bostanci, Account Manager OEM, Owen Mumford Ltd
“Perfect blend of theory and practicality that allowed the attendees to process and apply the information to real world scenarios. Extremely valuable taster into the world and benefits of an MBA!”
Dave Wood, Account Director, PharmiWeb Solutions
“Good”
Kevin Polhill, Quality and Regulatory Compliance Specialist, Invicta Compliance
“This was a well-organised course and both the content and speakers were very good. I do think that the topics could have been tied together better in some instances in the same way as the strategy tools we covered. Some elements such as project management were covered far too quickly to be of any use. ”
Emma Woods, Pharmaceutical Development Innovation Lead, AstraZeneca Pharmaceuticals Development
“Few topics to develop”
Edmondo Corona, Plan Engineering Director, AbbVie
“An excellent course. I would recommend to all wanting a flavour of an MBA.”
Bindu Patel, Senior Manager , Sanofi Pasteur MSD